MISA to NRDS:a Multicenter Study in China

NACompletedINTERVENTIONAL
Enrollment

237

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

November 30, 2018

Study Completion Date

March 30, 2019

Conditions
Bronchopulmonary DysplasiaPatent Ductus ArteriosusIntraventricular HemorrhageNecrotizing EnterocolitisPeriventricular Leukomalacia
Interventions
PROCEDURE

Minimal Invasive surfactant administration

Participants enrolled spontaneously breathing preterm infants born between 26.1 and 31.9 weeks' gestational age with signs of respiratory distress syndrome. Preterm infants of the MISA (Minimal invasive surfactant administration) group were assigned to receive surfactant (Calf pulmonary surfactant, Double-Crane Pharmaceutical Co., China) via a 5Fr nasogastric tube with an ophthalmic surgery straight forceps during CPAP/NIPPV-assisted spontaneous breathing.

Trial Locations (1)

Unknown

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER

NCT04077333 - MISA to NRDS:a Multicenter Study in China | Biotech Hunter | Biotech Hunter